Neimeth International Pharmaceuticals Past Performance
How has Neimeth International Pharmaceuticals performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NEIMETH is currently unprofitable.
Growing Profit Margin: NEIMETH is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: NEIMETH is unprofitable, but has reduced losses over the past 5 years at a rate of 1.3% per year.
Accelerating Growth: Unable to compare NEIMETH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NEIMETH is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (22.9%).
Return on Equity
High ROE: NEIMETH has a negative Return on Equity (-25.92%), as it is currently unprofitable.